Home » Topics » BioWorld Science

BioWorld Science
RSS

New prodrugs of PIN1 inhibitors discovered at the University of California

March 4, 2022

Abm Therapeutics identifies new AXL/PAK1/c-KIT/RET/MAP4K1 inhibitors

March 4, 2022

Clarity Pharmaceuticals describes new radiopharmaceuticals

March 4, 2022

Researchers present new murine model of aeroallergen-induced EoE

March 4, 2022

Infection in thymus causes autoimmunity in stomach

March 3, 2022

Intranasal COVID-19 booster BW-1019 provides protection and boosts immune response in hamsters

March 3, 2022

9 Meters collaborates with NYU Langone Health to evaluate NM-102 for autoimmune disorder

March 3, 2022

PMN-310 shows cognitive benefit in mouse model of Alzheimer's disease

March 3, 2022

Adagene and Sanofi collaborate on masked monoclonal and bispecific antibodies for immuno-oncology

March 3, 2022

Novel IL-33-dependent mouse model of eosinophilic esophagitis

March 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...